Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

NANot yet recruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2029

Conditions
Cancer Therapy-Related Cardiac Dysfunction
Interventions
OTHER

Rehabilitation Program

"Three of the five weekly sessions will take place at the gym in the Functional Unit of Breast Tumors at INCAN, under the supervision of Physical and Sports Medicine specialists and three physical therapists. These sessions allow for personalized feedback, enabling participants to confidently perform prescribed aerobic exercises at home on the remaining two days.~Each session starts with a 10- to 15-minute warm-up focused on joint mobility. Aerobic training is conducted at moderate intensity (40-59% VO2max or heart rate reserve), monitored with a Polar® FT1 device. Intensity is periodically adjusted based on the Borg Rating of Perceived Exertion and the talk test. Over 4-6 weeks, session duration will gradually increase to 90 minutes per week, remaining consistent thereafter.~Following aerobic training, resistance exercises targeting major muscle groups are performed using gym machines and dumbbells. The program includes seven exercises, progressively increasing load over 3-4 weeks."

OTHER

No Rehabilitation Program

The control group will continue standard oncological treatment in addition to general recommendations regarding diet and physical activity, but without a structured exercise protocol.

Trial Locations (2)

14080

Instituto Nacional de Cancerología (INCAN), Mexico City

National Institute of Cancerology (INCAN), Mexico City

All Listed Sponsors
collaborator

Instituto Nacional de Cancerologia de Mexico

OTHER

lead

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER